The decision is bigger than “which side?”
A patient arrives with seizures that continue despite treatment. The team must answer several questions: Are all the events epileptic? Is there a treatable focal source or network? What evidence supports that hypothesis? What functions would be at risk? Does the expected benefit justify the burden and risk for this particular person?
This guide follows the reasoning behind those questions. It is written for an engineering student observing an epilepsy service, not as instructions for evaluating a patient independently. The main example is focal epilepsy; childhood developmental disorders, generalized epilepsies, and hemispheric syndromes can follow different pathways.
The ten-day placement below is an invented teaching schedule across several cases and archived examples. One person’s assessment may span months. Tests may run in parallel, be repeated, or be unnecessary. Local clinicians determine the actual pathway.
For the engineer
For every result, ask: what was measured, under which conditions, where was it sampled, and what uncertainty remains? A colorful map is an estimate with a history, not a surgical instruction.
For the observer
Listen for how the patient describes the burden of seizures and what they most want to preserve. Use approved, de-identified teaching material. Observation of clinical care requires local permission and patient consent.
Drug resistance prompts specialist evaluation—not automatic surgery.
The ILAE definition requires failure to achieve sustained seizure freedom after adequate trials of two tolerated, appropriately selected and used antiseizure medication regimens, alone or in combination. Merely counting prescriptions is insufficient. Clinicians reconstruct the drug, indication, dose and duration, adherence, response, and reason for stopping. An inadequately documented or unsuitable trial may be uninformative rather than evidence of resistance. [1]
The 2022 ILAE expert consensus supports prompt surgical-evaluation referral once drug resistance is established, with age and clinical circumstances addressed in its recommendations. Referral also creates an opportunity to reconsider diagnosis and optimize other care. It should not be delayed simply because surgery feels like a “last resort.” [2] NICE likewise recommends referral for assessment in drug-resistant epilepsy, including when MRI shows no abnormality; selected structural lesions can justify earlier specialist assessment. These recommendations support evaluation, not an obligation to undergo an operation. [4]
What the first visit needs to establish
The specialist reviews the history, witness descriptions, prior recordings, and treatment record. Events such as syncope or functional seizures can resemble epileptic seizures; a person can also have more than one event type. A normal routine EEG does not exclude epilepsy. The clinical history and appropriately chosen investigations remain essential. [6]
Student task: construct a blank medication-trial table with columns for “known,” “missing,” and “uncertain.” Explain why “two medicines listed” and “two adequate treatment failures” are different data states.
A team builds the case with the patient.
Presurgical assessment brings together neurological, cognitive, psychological, and social information. The roles below are a practical orientation; titles and responsibilities differ between centers. [7]
| Person or group | Question they bring to the discussion |
|---|---|
| Patient, family, and caregivers | What actually happens during habitual events? Which outcomes and possible losses matter most? |
| Epileptologist / clinical neurophysiologist | What epilepsy pattern best explains the history, recordings, and seizure evolution? |
| EEG technologists and EMU nurses | Are the signals usable and events documented? Is the patient safe during monitoring? |
| Neuroradiologist and nuclear-medicine team | What structural or functional abnormality is present, and how reliable is it? |
| Neuropsychologist; psychiatry / psychology | What are the cognitive strengths, vulnerabilities, mood concerns, and expectations? |
| Neurosurgeon and anesthesiologist | Is the proposed intervention feasible, and what neurological and general medical risks accompany it? |
| Specialist nurses, social workers, rehabilitation staff | What support, communication, recovery planning, and follow-up does the person need? |
The multidisciplinary discussion integrates these views. It does not replace informed, shared decision-making with the patient.
A branching pathway, not a conveyor belt.
Phase 1 establishes a noninvasive hypothesis. Selected patients need Phase 2 intracranial recording to resolve an actionable uncertainty. Others proceed without it, or do not become surgical candidates. [3]
Understand the events, drug resistance, and patient goals.
Build an anatomical and electroclinical hypothesis.
Assess benefit, functional risk, and suitability for a proposed treatment.
Targeted imaging / mapping; consider Phase 2 recording if it can resolve the uncertainty.
Reconsider the hypothesis or discuss other treatment options.
An operation, further testing, another therapy, or no operation can all be legitimate outcomes.
Imaging order: structural MRI usually provides the anatomical foundation. Additional modalities are selected for the question, availability, and existing findings—not because everybody must complete MRI → PET → SPECT → MEG → SEEG. Functional-risk testing may proceed alongside localization. Re-review of earlier data is common. [26]
Six maps that should not be collapsed into one.
| Concept | What it means | Why it is not a resection mask |
|---|---|---|
| Structural lesion | An anatomical abnormality, for example on MRI. | Its borders may differ from the tissue involved in generating seizures. |
| Irritative zone | Regions producing interictal epileptiform discharges. | Spiking may be broader than seizure onset. |
| Seizure-onset zone (SOZ) | Where the earliest ictal activity is observed with the available recording. | “Earliest observed” depends on electrode coverage and detectability. |
| Symptomatogenic zone | Regions whose involvement produces the observed symptoms. | The first obvious symptom may follow propagation. |
| Epileptogenic zone / network | The hypothesized tissue or network that must be treated to achieve seizure freedom. | It is inferred from multiple observations, not directly measured by one test. |
| Eloquent cortex and important pathways | Structures supporting functions such as movement, language, and vision. | They constrain the risks of a potential intervention. |
Conceptual distinctions summarized from clinical presurgical literature. Terminology and network models continue to evolve. [5] [23]
Integrate the evidence + uncertainty + patient priorities
→ a clinical discussion, not an automatic mask
Lateralization asks which hemisphere; localization asks which region or network. A proposed surgical site and its boundaries require substantially more information than a left/right answer.
The story is part of the measurement.
Clinicians ask about the earliest remembered sensation, awareness, movements, speech, duration, recovery, triggers, and whether there are several event types. Witness accounts and available video can supplement an incomplete memory. Examination and earlier investigations provide additional context. Diagnostic tests support this assessment rather than replacing it. [6]
Observation exercise: separate description from inference
Description: “The patient stopped responding, then made repetitive hand movements.” Inference: “This arose from region X.” The first is an observation; the second needs supporting evidence. Record the order of events and the source of the description rather than silently converting a symptom into a localization label.
Ask your supervisor: “Which part of this story suggests onset, which may reflect spread, and what alternative hypothesis would produce a similar event?” Do not use this vignette to localize an actual patient.
Different measurements answer different questions.
EEG and MEG measure electrophysiology; MRI describes anatomy or, with specialized acquisitions, indirect functional signals and diffusion. PET and SPECT use radiotracers. They are not interchangeable pictures of “the epilepsy.” The cards below are a reading guide, not a required test list.
Epilepsy-protocol structural MRI
ANATOMYQuestion: is there a plausible structural substrate? Readers look for findings such as hippocampal atrophy and signal change, cortical malformations, tumors, or vascular abnormalities. The ILAE HARNESS protocol combines high-resolution 3D T1, 3D FLAIR, and high-resolution coronal T2 imaging. T1 helps assess morphology, FLAIR highlights some signal abnormalities, and T2 supports detailed hippocampal assessment. [8]
Work and uncertainty: small lesions, motion, acquisition choices, and reader expertise matter. “MRI-negative” means no lesion was identified on that examination, not that a structural cause is impossible. Expert re-review or repeat imaging may be appropriate when earlier scans were inadequate or surgery is considered. [9]
Engineering lens: retain sequence names, voxel size, orientation, acquisition date, motion assessment, and processing history. A segmentation or postprocessing alert is a candidate for review, not a diagnosis.
Interictal FDG-PET
METABOLISMQuestion: is there regional metabolic dysfunction that supports a hypothesis, particularly when MRI is unrevealing or results conflict? Clinicians often look for relatively reduced glucose metabolism between seizures. The abnormal territory may extend beyond the onset region. Recent seizures and acquisition conditions affect interpretation; PET is reviewed with EEG and MRI rather than used as a precise surgical boundary. [10]
Engineering lens: preserve the relation between seizure timing, tracer administration, and acquisition. Distinguish an image acquired during a visit from the physiological period it represents.
Ictal and interictal SPECT
PERFUSIONQuestion: where did perfusion increase around a captured seizure? Tracer is administered during the event and scanning follows later. The EANM guideline emphasizes rapid injection, ideally within 20 seconds of onset. Delay can make propagation dominate the pattern. Subtraction of interictal from ictal images, registered to MRI—often called SISCOM—helps display differences, but still requires electroclinical interpretation. [10]
Engineering lens: three timestamps matter: seizure onset, injection, and scan. Their meanings differ. An overlay without injection latency can hide a decisive limitation.
MEG and EEG source imaging
ESTIMATED SOURCESMEG records magnetic fields associated with brain activity and can support mapping of epileptiform activity or important functions. It requires specialized equipment and careful handling of movement and noise. [11] EEG source imaging estimates generators from scalp measurements using anatomical and mathematical models. Research comparing source estimates with intracranial findings supports its complementary role; it does not turn an inverse solution into direct observation of all seizure-generating tissue. [12]
Engineering lens: sensor positions, registration, head-model assumptions, event selection, and source uncertainty belong beside the colored localization map. A cluster of interictal sources is not automatically the ictal onset zone.
Task fMRI
FUNCTIONAL RISKQuestion: how are language or other relevant functions organized, and what postoperative cognitive risk might be anticipated? Task fMRI uses blood-oxygen-level-dependent changes as an indirect marker. The AAN guideline supports selected language and memory applications, with recommendations depending on the clinical setting and strength of evidence. Task performance, motion, processing, and medications influence results. An absent activation does not certify that tissue is expendable, and fMRI is not a scan of seizure onset. [13]
Diffusion MRI and tractography
PATHWAYS AT RISKQuestion: how might a proposed intervention relate to important white-matter pathways, such as optic radiations? Tractography estimates pathways from water-diffusion measurements. Method, seed placement, and reconstruction assumptions can produce different apparent boundaries. Both underestimation and overestimation matter for planning. Streamlines are model outputs, not photographs of individual axons. [14]
CT and vascular imaging around implantation
POSITION & SAFETYImaging helps plan and verify intracranial electrode placement; postoperative CT can locate the contacts. These images answer positioning and safety questions rather than independently identifying seizure onset. Vascular assessment and the precise imaging combination depend on the center and planned procedure. [15] UCLH, for example, describes vascular imaging before intracranial telemetry in its local patient pathway. [20]
Engineering lens: coordinate systems, left/right orientation, image registration, contact labels, and quality checks are safety-critical data dependencies. A millimeter-looking coordinate should never imply millimeter-level certainty.
Wait for events. Record continuously. Review selectively.
In an epilepsy monitoring unit (EMU), scalp EEG and synchronized video capture the event’s electrical and behavioral evolution. Staff document clinical changes while maintaining safety and signal quality. Johns Hopkins describes continuous recording and a usual stay of three to seven days in its service. That is a center example, not a guaranteed admission length. [16]
Capturing habitual events helps determine whether they are epileptic and how their clinical sequence relates to EEG changes. Specialist teams may adjust medication during monitored admission to increase the chance of recording events; this is supervised hospital practice, not something patients or students should reproduce independently. Event frequency and whether representative event types have been captured affect when sufficient evidence is available. [17]
What the engineer sees
Channels, samples, video frames, event buttons, annotations, and timestamps.
What the clinician asks
Was this the patient’s usual event? What changed first? Was the apparent onset obscured? Are other recorded events similar?
Observation assignment: watch an approved teaching recording with a supervisor. Make separate rows for video observations, EEG annotations, artifact, and uncertainty. Check synchronization before arguing about which came first. Your objective is to understand the review process, not to diagnose the recording.
Localization and preservation must be considered together.
Neuropsychological and psychological assessment
Standardized assessment establishes cognitive and behavioral baselines, contributes to the clinical formulation, informs risk prediction, and supports counseling and postoperative comparison. It examines more than “which side is weak”: memory, language, attention, executive abilities, psychosocial functioning, and the person’s expectations can all matter. Scores need interpretation in the context of education, language, development, mood, and other influences. Low baseline performance does not mean there is nothing important left to preserve. [18]
Wada testing in selected cases
The Wada procedure temporarily suppresses function in one hemisphere through an arterial medication injection while language and memory are tested. It is invasive and is not required for every patient. Teams decide whether it adds useful information beyond other assessments. Cleveland Clinic describes a total test time of about three to four hours, varying by center. [19]
Electrical stimulation mapping
Specialists can stimulate selected sites and observe effects during tasks such as naming or movement. Mapping may occur during invasive monitoring or an operation. EEG monitoring helps detect stimulation-related discharges or seizures. Duration varies with the territory and tasks; the Epilepsy Foundation describes roughly an hour to several hours. Results inform functional risk rather than guaranteeing that every unmapped site is safe. [21]
“No response observed” may refer to a particular task, site, session, or technical condition. A clinical report should make those conditions clear. For an engineer, preserving the test context is as important as storing a yes/no label.
SEEG tests a hypothesis. It cannot search the whole brain.
When noninvasive findings are insufficient or conflicting, intracranial recording may clarify a potentially actionable hypothesis. Depth electrodes sample selected three-dimensional locations; subdural grids or strips sample cortical surfaces differently. These are invasive investigations with risks including bleeding, infection, and neurological injury. The possible information gain must justify those risks. [22]
A useful implantation hypothesis includes possible onset sites, competing explanations, and expected spread. Coverage is deliberately selected, not complete. If the true onset lies outside that coverage, the first recorded change can be propagation. This is why implantation planning depends so strongly on the earlier work-up. [23]
Original conceptual diagram. Nodes do not represent actual anatomy, electrode trajectories, or an implantation plan. On a small screen, scroll the diagram horizontally.
After placement, the team verifies electrode identity and location, records events, and may perform functional or seizure stimulation studies. Recording and treatment can be separate admissions. The surgical plan is reconsidered after the findings are integrated; implanting electrodes does not commit the patient to resection. [22]
Look at timing, evolution, anatomy, and the habitual seizure together.
Experts assess intracranial ictal and interictal patterns, their spatial distribution, and their relationship to symptoms. Low-voltage fast activity is one possible seizure-onset pattern; other onset morphologies occur. Neither the largest amplitude nor the highest spike count provides a universal answer. Stimulation findings add context but require their own interpretation. [24]
Low-voltage fast activity can reflect propagation. Symptoms preceding the first recorded change can suggest missed onset. Both observations require reassessing the anatomical and electroclinical hypothesis. [3]
| During an observed review, ask… | Record in your learning notes… |
|---|---|
| Which event is this? | Event identifier and whether it represents a habitual seizure type. |
| Which interval supports the statement? | Start/end timestamps and the exact channels displayed. |
| What were the display conditions? | Montage, filters, gain, time scale, and visible artifact. |
| What is observation versus interpretation? | Separate waveform description from the inferred role of a region. |
| What remains uncertain? | Unsampled locations, competing explanations, or inconsistent events. |
This is a student documentation exercise, not a diagnostic scoring rule.
What about high-frequency oscillations and AI biomarkers?
Promising associations must be distinguished from evidence that biomarker-guided intervention improves outcomes. In the 2022 randomized HFO trial, HFO-guided intraoperative tailoring did not establish non-inferiority to spike-guided tailoring overall. Its setting and results should not be generalized to every HFO method, but it illustrates why a plausible marker requires prospective evaluation. [25]
Onset’s synthetic 120 Hz bursts and interictal features are teaching ingredients. Its contact rankings do not replicate the multimodal clinical decision described here.
Agreement is useful. Contradictions are work to do.
The team reviews the overall evidence and possible benefits and harms before discussing a recommendation with the patient. The available treatment family can include resection, ablation, disconnection, or neuromodulation, depending on the individual condition and goals. Some interventions aim at seizure freedom; others aim mainly to reduce burden. Further evaluation or continued nonsurgical treatment may be the appropriate outcome. [26]
A teaching template for presenting a case
- Patient goal and disease burden: what problem are we trying to improve?
- Evidence inventory: which events, scans, tests, and reports are available?
- Leading hypothesis: what explains onset and spread?
- Contradictions: which findings do not fit, and could quality or sampling explain them?
- Functional and procedural risks: what could change if the proposed tissue or network were treated?
- Options and uncertainty: what choices remain, and what additional evidence could change them?
- Patient discussion: how will benefits, risks, alternatives, and unresolved questions be communicated?
The template is an educational synthesis, not an official clinical form. There is no “three tests agree, therefore operate” rule.
General medical and anesthetic assessment, individualized consent, and recovery planning are also part of preparation. Follow-up looks beyond a single early seizure count: later seizure control, cognition, mood, complications, function, and quality of life matter. Local follow-up schedules and medication decisions vary. [20]
Why this can take months
A scan’s acquisition time is only one part of the pathway. Recording must capture useful events; specialists must interpret and reconcile findings; appointments and multidisciplinary reviews must be coordinated. These clocks should never be added together as if every patient follows the same schedule.
| Activity | Published example, not a universal promise | What that time means |
|---|---|---|
| Core structural MRI | HARNESS core sequences: approximately 30 minutes or less [8] | Core acquisition; additional sequences, preparation and reporting take additional time. |
| Scalp video-EEG admission | Usually 3–7 days at Johns Hopkins [16] | Continuous observation; useful events may occur unpredictably. |
| FDG brain PET | 20–30 minutes scanning; 2–3 hours in the department in UHB’s leaflet [27] | The appointment includes more than image acquisition. |
| MEG | About 1–2 hours at Cleveland Clinic [11] | Recording appointment, not the complete source-analysis workflow. |
| Neuropsychological assessment | Several hours; Cleveland Clinic’s general assessment guidance [28] | Depends on the questions, battery, patient tolerance and breaks. |
| Wada test, when indicated | Approximately 3–4 hours at Cleveland Clinic [19] | Includes procedural preparation and recovery. |
| SEEG electrode implantation | Approximately 4–6 hours at Cleveland Clinic [15] | The operation to place electrodes; subsequent recording is separate. |
| Intracranial monitoring | Approximately 3 days–2 weeks at Johns Hopkins [22] | Duration depends on the required evidence and clinical circumstances. |
| Electrical stimulation mapping | One to several hours, according to the Epilepsy Foundation [21] | Depends on the functions and locations tested. |
There is no defensible universal “doctor-hours per patient” number in this guide. For an engineering project, measure actual review time, interruptions, repeated annotations, registration checks, and report preparation at the intended service. A recording lasting seven days does not imply that a doctor watches every second at normal speed.
More data do not automatically remove ambiguity
Incomplete observation
Electrodes sample selected locations. A deep or unrecorded source may spread before it becomes visible. Even intracranial coverage is a hypothesis-driven sample, not a complete measurement of the brain. [23]
Several plausible explanations
Different onset patterns, early propagation and artifacts can complicate interpretation. A short attractive waveform needs its surrounding recording and clinical context. [24]
Normal-looking anatomy
A negative MRI does not settle the surgical question. Expert review or additional imaging may be appropriate when the clinical evidence remains suggestive. [9]
A target can overlap a function
Language and memory assessment addresses consequences of intervention. Localizing seizure activity and judging an acceptable functional risk are different tasks. [13]
What does “subjective” actually mean?
Experts exercise judgment under incomplete information; that does not make their decisions arbitrary. A prospective study of expert interictal-discharge interpretation found agreement depended on whether the task concerned an individual waveform or an entire EEG. It demonstrates an annotation-reliability problem, not the error rate of epilepsy surgery or a measure of agreement on surgical plans. [29]
Same pathway. Different open questions.
These invented cases are discussion exercises, not decision rules or recommendations for a real patient. Open each case and identify what would change your confidence.
A · Several findings point in the same direction
Evidence packet: habitual events have a consistent sequence; recorded seizures lateralize to the left temporal region; expert MRI review identifies a plausible left temporal abnormality. Neuropsychological and language findings require careful consideration.
Interpretation: concordant evidence strengthens a localization hypothesis, but it does not establish that every visible abnormality should be removed or that cognitive risk is acceptable.
Conference question: what additional information is needed to estimate functional consequences, discuss alternatives, and understand this patient’s priorities?
B · MRI is negative, but the events are stereotyped
Evidence packet: repeated habitual events are similar, scalp EEG offers incomplete localization, and the original MRI report is normal.
Interpretation: “MRI negative” describes an imaging result. It does not mean “no epilepsy” or automatically rule out further surgical evaluation.
Conference question: would expert MRI review or a targeted complementary test discriminate between the competing hypotheses? If intracranial recording is considered, what specific hypothesis would electrode coverage test?
C · Different tests suggest different sides
Evidence packet: an anatomical abnormality is on one side, some interictal activity occurs on the other, and recorded habitual events do not yet resolve the discrepancy.
Interpretation: counting tests as votes ignores their different biological meanings, quality, sampling and timing.
Conference question: could propagation, incidental anatomy, technical error or more than one seizure network explain the findings? What evidence would resolve that question, and when might further invasive investigation have little useful value?
Ten days inside the team’s questions
This is a teaching itinerary spanning different patients and stages of care. It does not imply that one patient completes evaluation in ten days. Observation requires the service’s permission, patient consent where applicable, supervision, and appropriate handling of patient information. Use synthetic or approved de-identified material for assignments.
Understand the person and the events
Observe how the clinician reconstructs habitual seizures and medication history. Ask what makes a trial adequate and which uncertainties remain in the diagnosis.
Deliverable: an event timeline and a medication-trial table, with unknowns explicitly marked.Learn how evidence is captured
Follow electrode checks, synchronized video, event marking and handover. Compare a patient-reported event with its recording and the reviewer’s annotation.
Deliverable: one annotated event with separate observed behavior, signal finding and interpretation.Read anatomy with a question
Observe an epilepsy-focused MRI review. Ask how acquisition quality and prior clinical information affect what the reader can conclude.
Deliverable: an imaging checklist that distinguishes “not seen,” “not assessed,” and “technically limited.”Why this test for this patient?
Discuss PET, SPECT, MEG or source imaging with the team. These need not all be performed. Follow the question that justified the chosen investigation.
Deliverable: a test-selection explanation, including the relevant timing and a limitation.Understand function and priorities
Learn how cognitive history, testing and patient goals contribute to risk discussions. Avoid treating a test score as a complete account of someone’s abilities.
Deliverable: a patient-centered list of outcomes that seizure counts alone would miss.Turn a hypothesis into coverage
Using a teaching case, ask which competing explanations each proposed electrode could help distinguish. Identify the regions that would remain unobserved.
Deliverable: a coverage diagram labeled “sampled,” “unsampled,” and “question being tested.”Follow onset and spread
Compare several events with a supervised reviewer. Note the first visible change, display settings, later evolution and whether events are clinically habitual.
Deliverable: a reproducible evidence packet rather than one cropped “best” waveform.Ask what intervention might affect
Discuss how mapping tasks and patient performance shape interpretation. Record the context of a negative result as carefully as a positive response.
Deliverable: a function-versus-localization table with remaining uncertainties.Watch evidence become a proposal
Observe how specialists reconcile discordance, discuss options and describe risk. Then consider how a patient might value the tradeoffs differently.
Deliverable: a one-page conference brief with evidence, disagreement and questions for shared decision-making.Close the engineering loop
Discuss outcomes and the limitations of retrospective labels. Identify one workflow burden, observe it, and define how an improvement would be measured.
Deliverable: a prototype specification with a baseline, success measure and failure conditions.Save effort without hiding the evidence
The useful engineering question is precise: which task becomes faster or more reliable, for whom, and with what new failure modes? “AI finds the seizure focus” is too broad to evaluate.
| Observed burden | Candidate engineering contribution | How to test the benefit |
|---|---|---|
| Finding the same event across tools | Linked EEG, video and imaging references with synchronized timestamps | Time to retrieve the correct evidence; wrong-event retrieval rate |
| Repeated manual annotation | Candidate-event triage with editable annotations and an audit trail | Missed events, false alerts and total reviewer time |
| Unclear channel or coordinate identity | Explicit montage, electrode and registration provenance | Mapping errors detected before interpretation |
| Rebuilding a conference summary | Evidence-linked draft tables with unresolved disagreements | Correction burden, omitted evidence and citation accuracy |
| Overconfidence in a model score | Visible alternatives, uncertainty and data-quality context | Calibration and performance across patients, sites and subgroups |
Recording-size lab
Invented uncompressed signal example; excludes video, metadata and storage overhead. This measures data volume, not clinical review time.
128 × 1,024 × 604,800 × 2 = 158.5 GB of signal samples.
Formula: channels × samples/second × days × 86,400 × bytes/sample. GB uses 10⁹ bytes.
Where Onset fits
Onset is a synthetic teaching prototype: signals, features, two rankings, evidence windows, a report and a constrained assistant. It does not ingest real clinical imaging, plan electrode trajectories, model cognitive risk, or establish a safe surgical target. Its useful lesson is how to make a proposed finding inspectable.
An LLM could help retrieve an already verified observation or draft an evidence-linked summary. It must not turn a rank into a surgical instruction. Tool permissions, patient scope, provenance and evaluation matter as much as fluent language. Explore the Qwen teaching lab and model evaluation chapter.
Could you explain the case without overselling it?
- Explain why referral for surgical evaluation is different from deciding to operate.
- Distinguish a lesion, interictal-discharge source, recorded SOZ, inferred epileptogenic zone and functional boundary.
- Explain which question MRI, PET, ictal SPECT, MEG, fMRI and intracranial EEG address.
- Describe a plausible reason for discordance that does not assume one specialist is wrong.
- Separate a scan’s acquisition time from event sampling, expert review and pathway waiting.
- Explain why the first recorded channel is not necessarily the biological origin.
- Propose one engineering improvement and a study that could show whether it actually helps.
Abbreviations
DRE: drug-resistant epilepsy. EMU: epilepsy monitoring unit. iEEG: intracranial EEG. SEEG: stereoelectroencephalography. SOZ: seizure-onset zone. EZ: epileptogenic zone. IED: interictal epileptiform discharge. FDG: fluorodeoxyglucose. MEG: magnetoencephalography. SISCOM: subtraction ictal SPECT coregistered to MRI. DTI: diffusion tensor imaging. MDT: multidisciplinary team.
Sources you can follow
Guidelines and consensus documents establish the clinical framework; hospital pages provide explicitly local timing examples; primary studies illustrate methodological limits. Sources checked September 19, 2026. This educational synthesis has not undergone independent clinical review.
- ILAE — Definition of drug-resistant epilepsy (2010)
- ILAE expert consensus — Timing of referral to evaluate for epilepsy surgery (2022)
- Schuele et al. — Seminars in epileptology: presurgical epilepsy evaluation (2025)
- NICE NG217 — Non-pharmacological treatments
- Baumgartner et al. — Presurgical epilepsy evaluation and epilepsy surgery (2019)
- Johns Hopkins — Diagnosing seizures and epilepsy
- Epilepsy Foundation — Tests before epilepsy surgery
- ILAE Neuroimaging Task Force — Structural MRI recommendations / HARNESS (2019)
- NICE NG217 — Diagnosis and assessment
- EANM — Practice guidelines for PET and SPECT in epilepsy (2024)
- Cleveland Clinic — Magnetoencephalography
- Primary study — EEG source imaging in presurgical evaluation (2021)
- American Academy of Neurology — fMRI presurgical evaluation guideline (2017)
- Winston et al. — Optic-radiation tractography: comparison of methods (2011)
- Cleveland Clinic — SEEG test
- Johns Hopkins — Epilepsy monitoring unit
- Epilepsy Foundation — Video EEG
- ILAE — Neuropsychological assessment in epilepsy surgery (2019)
- Cleveland Clinic — Wada test
- UCLH — A guide for patients considering epilepsy surgery
- Epilepsy Foundation — Brain mapping
- Johns Hopkins — Intracranial monitoring for epilepsy
- Khoo et al. — Technical aspects of SEEG (2020)
- Frauscher et al. — Learn how to interpret and use intracranial EEG findings (2024)
- Zweiphenning et al. — HFO trial: randomized comparison of intraoperative guidance (2022)
- Cleveland Clinic — Epilepsy surgery
- University Hospitals Birmingham — FDG brain PET patient information
- Cleveland Clinic — Neuropsychological testing and assessment
- Jing et al. — Interrater reliability of experts identifying interictal discharges (2020)